Several clinical trials at the University of Cincinnati (UC) are focused on potential treatments for two serious gastroenterological illnesses—Crohn’s disease and Clostridium difficile, or C. difficile.
Mar 20, 2012
3
0
(HealthDay) -- Recurrent Clostridium difficile (C. difficile) infection (CDI) can successfully be treated in the vast majority of patients through a fecal transplantation procedure via colonoscopy, according to research published ...
Mar 3, 2012
0
0
Researchers have combined bioactive peptides to successfully stimulate wound healing. The in vitro and in vivo study, published today in PLoS ONE, demonstrates that the combination of two peptides stimulates the growth of ...
Feb 24, 2012
0
0
Contrary to current convention by which infection with the organism Clostridium difficile is regarded as an infection that is acquired by contact with symptomatic patients known to be infected with C. difficile, these may ...
Feb 7, 2012
0
0
Norovirus, a pathogen that often causes food poisoning and gastroenteritis, was responsible for 18.2 percent of all infection outbreaks and 65 percent of ward closures in U.S. hospitals during a two-year period, according ...
Jan 31, 2012
0
0
Yet another study adds to the growing evidence that antibiotics can disrupt the balance of the intestinal flora, with negative effects on health. A team of researchers from the Memorial Sloan Kettering Cancer Center, New ...
Jan 20, 2012
0
0
Even a very good wastewater treatment plant can't clean up fragments of superbugs -- bacteria that have developed a resistance to antibiotics -- and until now, almost no one has noticed.
Nov 21, 2011
1
0
MGB Biopharma, a biopharmaceutical company which has licensed technology from the University of Strathclyde in Glasgow, Scotland, is developing a powerful new antibiotic treatment for resistant infections including the deadly ...
Sep 19, 2011
0
0
New research has identified a novel mechanism by which humans can defend themselves against the well known hospital superbug, Clostridium difficile. The study provides us with critical information for the development ...
Jul 29, 2011
0
0
(Medical Xpress) -- UCSF basic research into botulism has translated into a novel antitoxin to protect against bioterrorism, with the first clinical trials launching soon to assess the resulting vaccine's safety.
May 6, 2011
0
0
